简体中文 | 繁體中文 | English

Press Releases

2018-04-10 09:58 ACA Compliance Group to Acquire Cordium
2018-04-10 09:54 Frost & Sullivan Best Practices Award: IDEMIA Awarded as the Company of the Year in the Global Biometric Authentication Solutions Market
2018-04-10 09:51 Berkshire Hathaway Specialty Insurance Introduces Executive First Private Company & Nonprofit Portfolio Policies in Asia
2018-04-09 21:00 Full-Screen Smartisan Nut 3 is First to Incorporate Elliptic Labs’ New Machine-Learning Platform
2018-04-09 18:22 AT TOKYO Launches Connection Services Between ATBeX and IX Services of 3 Major IX Providers in Japan
2018-04-09 18:14 L&T Technology Services Wins Multi-Million Dollar Digitalization Contract from ExxonMobil Exploration Company
2018-04-09 18:12 Spirent Announces New Global Partner Program
2018-04-09 15:25 U.S. DoD Contracts Full O3b MEO Beam and Services from SES Government Solutions
2018-04-09 11:28 XPRIZE Plans to Continue Lunar XPRIZE Mission
2018-04-09 11:22 Impossible Foods Announces $114 Million Convertible Note as Startup Prepares for Rapid Expansion in the US and Overseas
2018-04-09 10:16 SES Appoints John-Paul Hemingway as CEO of SES Networks
2018-04-09 10:03 HKBN & TVB Joint Press Conference cum HKBN Talent Meeting
2018-04-09 09:55 ABB to Invest €100 Million in Global Innovation and Training Campus
2018-04-09 09:34 ExxonMobil Awards FLEXICOKING™ Technology License to Sinochem Hongrun Petrochemical Co. Ltd.
2018-04-09 09:28 SES Shareholders Approve All Resolutions at Annual General Meeting
2018-04-09 09:26 Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.
2018-04-09 09:22 LYNC Factory and KINTEX Inked Business Collaboration Agreement to Launch the First-Ever Digital Healthcare Fair in Korea
2018-04-09 09:20 Viewers in the Caribbean Gain Access to New, High-Quality TV Offer with Kiwisat and SES Video
2018-04-09 09:13 Dame Maggie Smith and Other Harry Potter Film Actors Join Jam City’s Harry Potter: Hogwarts Mystery
2018-04-09 09:10 Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors

Business Wire Weibo

Industries

Latest Releases